id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-E-0791-0003,FDA,FDA-2021-E-0791,Letter to U S Patent and Trademark Office,Other,Letter(s),2022-08-24T04:00:00Z,2022,8,2022-08-24T04:00:00Z,,2022-08-24T14:50:49Z,,0,0,090000648526eb3b